NICEdrug.ch
NICEdrug.ch enables large-scale computational analysis of drug biochemistry, including metabolic precursors and prodrugs, their metabolic fate and degradation, enzymatic targets, and toxicity across human, Plasmodium, and E. coli metabolism.
Key Features:
- Extensive Database: Contains a collection of 250,000 bioactive molecules for systematic biochemical analysis.
- Unique Fingerprinting System: Identifies reactive similarities between drug–drug and drug–metabolite pairs to predict interactions and reactivity.
- Validation and Performance: Validated against golden standard datasets describing drugs and metabolites that share reactivity, drug toxicities, and drug targets.
- Inhibition and Toxicity Evaluation: Performs computational evaluation of inhibition and toxicity profiles of compounds, exemplified by analyses of 5-fluorouracil and proposed mitigation strategies.
- Target Identification for Disease Treatment: Proposes biochemical targets such as shikimate 3-phosphate for liver-stage malaria and suggests over 1,300 candidate drugs and food molecules to inhibit COVID-19 with insights into their inhibitory mechanisms.
Scientific Applications:
- Systematic Reactivity Identification: Enables systematic identification of small-molecule reactivity with druggable enzymes.
- Drug Repurposing Discovery: Facilitates identification of new therapeutic uses for existing bioactive molecules.
- Toxicity Prediction: Predicts toxicological profiles to inform safer drug design.
- Target Prioritization for Infectious Diseases: Supports identification and prioritization of biochemical targets and candidate inhibitors for pathogens including Plasmodium and SARS-CoV-2 (COVID-19).
Methodology:
Computational analysis of enzymatic metabolic targets, metabolic fate, and toxicity of bioactive molecules; data integration combining human, Plasmodium, and E. coli metabolism; reactivity analysis using the unique fingerprint system to analyze and predict reactivities between drugs and metabolites; validation against golden standard datasets describing shared reactivity, toxicities, and targets.
Topics
Details
- License:
- Not licensed
- Cost:
- Free of charge
- Tool Type:
- web application, workflow
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 12/20/2021
- Last Updated:
- 12/20/2021
Operations
Publications
MohammadiPeyhani H, Chiappino-Pepe A, Haddadi K, Hafner J, Hadadi N, Hatzimanikatis V. NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism. eLife. 2021;10. doi:10.7554/elife.65543. PMID:34340747. PMCID:PMC8331181.